| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-07 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.19 | 4e-05 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.22 | 6e-05 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |